← Back to Search

Behavioral Intervention

Maternal Diet for Preventing Food Allergies (ESCAPE Trial)

N/A
Waitlist Available
Research Sponsored by University of Rochester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Must not have
Renal/liver/cardiac insufficiency
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
No Placebo-Only Group

Summary

"This trial will study how a baby's risk of developing allergies to peanuts and eggs is affected by the mother's diet during pregnancy and breastfeeding."

Who is the study for?
This study is for expecting mothers who are not allergic to peanuts or eggs. It's designed to see if eating or avoiding these foods during pregnancy and breastfeeding affects their baby's risk of developing food allergies.
What is being tested?
The trial is testing the impact of maternal diet on infant allergy development. Specifically, it looks at whether mothers consuming or avoiding peanuts and eggs can influence their child's likelihood of having a peanut or egg allergy.
What are the potential side effects?
Since this trial involves dietary choices rather than medication, there aren't typical side effects. However, there may be risks associated with nutritional changes for the mother and potential allergy development in infants.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My kidneys, liver, or heart are not working properly.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~four months
This trial's timeline: 3 weeks for screening, Varies for treatment, and four months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Egg sensitization
Secondary study objectives
Antibodies in maternal blood
Antigen concentrations
Egg allergy
+1 more
Other study objectives
Exploratory: Peanut sensitization
Exploratory: Symptoms

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: Arm 2 ConsumptionActive Control1 Intervention
Subjects must consume peanuts and peanut products and egg and egg products.
Group II: Arm 1 AvoidanceActive Control1 Intervention
Subjects must avoid eating peanuts and peanut products and egg and egg products.

Find a Location

Who is running the clinical trial?

National Institute of Allergy and Infectious Diseases (NIAID)NIH
3,320 Previous Clinical Trials
5,364,245 Total Patients Enrolled
University of RochesterLead Sponsor
867 Previous Clinical Trials
548,482 Total Patients Enrolled
~267 spots leftby Sep 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top